Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Yan Yi Chan"'
Autor:
Yan Yi Chan, Pui Yan Ho, Carla Dib, Leah Swartzrock, Maire Rayburn, Hana Willner, Ethan Ko, Katie Ho, Julian D. Down, Adam C. Wilkinson, Hiro Nakauchi, Morgane Denis, Taylor Cool, Agnieszka Czechowicz
Publikováno v:
Stem Cell Research & Therapy, Vol 15, Iss 1, Pp 1-14 (2024)
Abstract Background Hematopoietic stem cell transplantation (HSCT) is a curative treatment for many diverse blood and immune diseases. However, HSCT regimens currently commonly utilize genotoxic chemotherapy and/or total body irradiation (TBI) condit
Externí odkaz:
https://doaj.org/article/9a2ae0133b43438e85f913fd5bb6f856
Hematopoiesis post anti-CD117 monoclonal antibody treatment in wild-type and Fanconi anemia settings
Autor:
Morgane Denis, Leah Swartzrock, Hana Willner, Quenton R. Bubb, Ethan Haslett, Yan Yi Chan, Anzhi Chen, Mark R. Krampf, Agnieszka D. Czechowicz
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Anti-CD117 monoclonal antibody (mAb) agents have emerged as exciting alternative conditioning strategies to traditional genotoxic irradiation or chemotherapy conditioning for both allogeneic and autologous gene-modified hematopoietic stem cell transp
Externí odkaz:
https://doaj.org/article/2c1acddebd3244a0b45e4ce8ebeb255a
Autor:
Agnieszka Czechowicz, Rahul Palchaudhuri, Amelia Scheck, Yu Hu, Jonathan Hoggatt, Borja Saez, Wendy W. Pang, Michael K. Mansour, Tiffany A. Tate, Yan Yi Chan, Emily Walck, Gerlinde Wernig, Judith A. Shizuru, Florian Winau, David T. Scadden, Derrick J. Rossi
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-12 (2019)
Hematopoietic stem cell (HSC) transplantation is a desirable treatment for many non-malignant and malignant diseases, but its use requires preconditioning of recipients with irradiation or chemotherapy that often induces high toxicity. Here the autho
Externí odkaz:
https://doaj.org/article/9ffac621975f4bccb6eaeafd10b5ba55
Autor:
Stefan Radtke, Dnyanada Pande, Margaret Cui, Anai M. Perez, Yan-Yi Chan, Mark Enstrom, Stefanie Schmuck, Andrew Berger, Tom Eunson, Jennifer E. Adair, Hans-Peter Kiem
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 18, Iss , Pp 679-691 (2020)
Hematopoietic stem cell (HSC) gene therapy has the potential to cure many genetic, malignant, and infectious diseases. We have shown in a nonhuman primate gene therapy and transplantation model that the CD34+CD90+ cell fraction was exclusively respon
Externí odkaz:
https://doaj.org/article/261752fffa134004b8b8adfca84f2e43
Autor:
Kyomi J Igarashi, Iwo Kucinski, Yan Yi Chan, Tze-Kai Tan, Hwei Minn Khoo, David Kealy, Joydeep Bhadury, Ian Hsu, Pui Yan Ho, Kouta Niizuma, John W Hickey, Garry Nolan, Katherine S Bridge, Agnieszka Czechowicz, Berthold Gottgens, Hiromitsu Nakauchi, Adam C Wilkinson
Hematopoietic stem cells (HSCs) are a rare hematopoietic cell type that can entirely reconstitute the blood and immune systems following transplantation. Allogeneic HSC transplantation (HSCT) is used clinically as a curative therapy for a range of he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2992d2e57974f834d61918b9f9c0247f
https://ora.ox.ac.uk/objects/uuid:2a38be79-3dcb-4a27-a289-044ce34d3cb8
https://ora.ox.ac.uk/objects/uuid:2a38be79-3dcb-4a27-a289-044ce34d3cb8
Autor:
Yan Yi Chan, Pui Yan Ho, Leah Swartzrock, Maire Rayburn, Rofida Nofal, Supawat Thongthip, Kenneth I. Weinberg, Agnieszka Czechowicz
Publikováno v:
Blood. 140:7342-7344
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb8c89d16df990c68a826d5d8c8f9730
https://doi.org/10.1182/blood-2022-164809
https://doi.org/10.1182/blood-2022-164809
Autor:
Rajni Agarwal, Alice Bertaina, Rofida Nofal, Gopin Saini, Nivedita Kunte, Sushmita Sen, Yan Yi Chan, Hana Willner, Matthias Felber, Mark R. Krampf, Maite Van Hentenryck, Emily Walck, Amelia Scheck, Supawat Thongthip, Aaron C. Logan, Kirstin Dougall, Alisha Bouge, Jaap Jan Boelens, Janel Renee Long-Boyle, Robertson Parkman, Irving L Weissman, Judith A. Shizuru, Wendy W. Pang, Maria Grazia Roncarolo, Matthew H. Porteus, Agnieszka Czechowicz
Publikováno v:
Transplantation and Cellular Therapy. 29:S163-S164
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4afc5943937afb70fd7627dcaf1a21b1
https://doi.org/10.1016/s2666-6367(23)00280-4
https://doi.org/10.1016/s2666-6367(23)00280-4
Autor:
Yan Yi Chan, Pui Yan Ho, Leah Swartzrock, Maire Rayburn, Rofida Nofal, Supawat Thongthip, Kenneth I. Weinberg, Agnieszka Czechowicz
Publikováno v:
Transplantation and Cellular Therapy. 29:164.e1-164.e9
Hematopoietic stem cell transplantation (HSCT) is a curative treatment for patients with many different blood and immune diseases; however, current treatment regimens contain nonspecific chemotherapy and/or irradiation conditioning, which carry both
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20e9b18497abf5da4ec3641180eebc5d
https://doi.org/10.1016/j.jtct.2022.08.015
https://doi.org/10.1016/j.jtct.2022.08.015
Autor:
Rofida Nofal, Yan Yi Chan, Sushmita Sen, Ulises Juarez Figueroa, Hana Willner, Matthias Felber, Mark Krampf, Supawat Thongthip, Grace Choi, Eileen Nicoletti, Jonathan D. Schwartz, Kenneth I. Weinberg, Alfredo Rodriguez, Rajni Agarwal, Maria Grazia Roncarolo, Agnieszka Czechowicz
Publikováno v:
Blood. 140:7772-7773
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4f9cbe71101ace1715cd5b88f23bee6
https://doi.org/10.1182/blood-2022-157840
https://doi.org/10.1182/blood-2022-157840
Autor:
Margaret Cui, Andrew Berger, Stefanie Schmuck, Jennifer E. Adair, Anai M. Perez, Yan-Yi Chan, Tom Eunson, Hans-Peter Kiem, Stefan Radtke, Dnyanada Pande, Mark Enstrom
Publikováno v:
Molecular Therapy. Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development, Vol 18, Iss, Pp 679-691 (2020)
Molecular Therapy: Methods & Clinical Development, Vol 18, Iss, Pp 679-691 (2020)
Hematopoietic stem cell (HSC) gene therapy has the potential to cure many genetic, malignant, and infectious diseases. We have shown in a nonhuman primate gene therapy and transplantation model that the CD34+CD90+ cell fraction was exclusively respon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::920b21f02a657c920794b84136a0fa70
http://europepmc.org/articles/PMC7424231
http://europepmc.org/articles/PMC7424231